{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T04:14:20Z","timestamp":1795061660194,"version":"4.10.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Postoperative endophthalmitis (PSE) is a severe ocular complication that can lead to irreversible vision loss or even globe atrophy. The Endophthalmitis Vitrectomy Study (EVS) historically guided PSE management but is increasingly questioned due to advances in pars plana vitrectomy (PPV) techniques and its narrow focus on cataract surgery. This study aimed to compare PPV followed by intravitreal antibiotic injection at the end of surgery (PPV\u2009+\u2009IVAIES) with intravitreal antibiotic injection alone (IVAI) in managing PSE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This randomized clinical trial included 35 pseudophakic patients with PSE following cataract extraction, anti-vascular endothelial growth factor (anti-VEGF) injections, or glaucoma surgeries. Participants were randomized to receive either PPV\u2009+\u2009IVAIES (n\u2009=\u200912) or IVAI (n\u2009=\u200923). Best-corrected visual acuity (BCVA) was assessed at baseline and days 7, 30, 60, and 90 post-intervention. Clinical worsening, defined as lack of improvement or progression of symptoms within 48\u201372\u00a0h, guided retreatment protocols. Group A (PPV\u2009+\u2009IVAIES) received repeat IVAI if required, while Group B (IVAI) underwent delayed PPV with repeat IVAI. Statistical significance was assessed using repeated measures ANOVA and logistic regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Both groups showed significant BCVA improvement (p\u2009&lt;\u20090.001). PPV\u2009+\u2009IVAIES resulted in faster recovery, with superior BCVA at day 7 (p\u2009=\u20090.019) and day 30 (p\u2009=\u20090.041). Retreatment was required in 39.1% of the IVAI group but not in the PPV\u2009+\u2009IVAIES group (p\u2009=\u20090.015). Subgroup analysis indicated a trend toward better early outcomes with early PPV (p\u2009=\u20090.029).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Early PPV\u2009+\u2009IVAIES provides faster visual recovery and reduces retreatment rates compared to IVAI alone. Multicenter studies are warranted to confirm these findings and refine clinical guidelines.<\/jats:p>\n            <jats:p>\n              <jats:italic>Trial registration<\/jats:italic> ClinicalTrials.gov identifier: NCT04192994.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40942-025-00640-1","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:08:31Z","timestamp":1739855311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Postoperative endophthalmitis treatment with antibiotics associated or not with pars plana vitrectomy: a randomized clinical trial"],"prefix":"10.1186","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04192994","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Vinicius Campos","family":"Bergamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Filipe","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilva Simeren Bueno","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Maynart","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Silveira","family":"De Queiroz Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luisa","family":"Hofling-Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"640_CR1","first-page":"95","volume":"9","author":"K Vaziri","year":"2015","unstructured":"Vaziri K, Schwartz SG, Kishor K, Flynn HW Jr. Endophthalmitis: state of the art. Clin Ophthalmol. 2015;9:95\u2013108.","journal-title":"Clin Ophthalmol"},{"key":"640_CR2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Results of the Endophthalmitis Vitrectomy Study","year":"1995","unstructured":"Results of the Endophthalmitis Vitrectomy Study. A Randomized Trial of Immediate Vitrectomy and of Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis. Arch Ophthalmol. 1995;113:1479\u201396.","journal-title":"Arch Ophthalmol"},{"key":"640_CR3","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00417-005-0082-8","volume":"243","author":"F Kuhn","year":"2005","unstructured":"Kuhn F, Gini G. Ten years after... are findings of the Endophthalmitis vitrectomy study still relevant today? Graefes Arch Clin Exp Ophthalmol. 2005;243:1197\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"640_CR4","doi-asserted-by":"publisher","first-page":"xx","DOI":"10.1016\/j.ajo.2017.11.021","volume":"187","author":"N Relhan","year":"2018","unstructured":"Relhan N, Forster RK, Flynn HW Jr. Endophthalmitis: then and now. Am J Ophthalmol. 2018;187:xx\u2013xxvii.","journal-title":"Am J Ophthalmol."},{"key":"640_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000003759","author":"AC Sen","year":"2023","unstructured":"Sen AC, Mehta SM, Sule A, More AV, Shetty SB, Singh J, et al. Immediate vitrectomy vs tap and inject in eyes with acute post-cataract endophthalmitis and visual acuity \u2265HM: a randomized clinical trial. Retina. 2023. https:\/\/doi.org\/10.1097\/IAE.0000000000003759.","journal-title":"Retina"},{"key":"640_CR6","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40942-023-00490-9","volume":"9","author":"VC Bergamo","year":"2023","unstructured":"Bergamo VC, Nakayama LF, Moraes NSBD, Yu MCZ, H\u00f6fling-Lima AL, Maia M. Bacterial endophthalmitis following anti-VEGF intravitreal injections: a retrospective case series. Int J Retina Vitreous. 2023;9:58.","journal-title":"Int J Retina Vitreous"},{"key":"640_CR7","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1159\/000534650","volume":"66","author":"P Panahi","year":"2023","unstructured":"Panahi P, Mirzakouchaki-Borujeni N, Pourdakan O, Ar\u00e9valo JF. Early vitrectomy for endophthalmitis: are EVS guidelines still valid? Ophthalmic Res. 2023;66:1318\u201326.","journal-title":"Ophthalmic Res"},{"key":"640_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2023.12.033","author":"RN Israilevich","year":"2024","unstructured":"Israilevich RN, Mansour H, Patel SN, Garg SJ, Klufas MA, Yonekawa Y, et al. Risk of endophthalmitis based on cumulative number of anti-vascular endothelial growth factor intravitreal injections. Ophthalmology. 2024. https:\/\/doi.org\/10.1016\/j.ophtha.2023.12.033.","journal-title":"Ophthalmology"},{"key":"640_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/aos.16727","author":"BS Thinggaard","year":"2024","unstructured":"Thinggaard BS, Pedersen F, Kawasaki R, Wied J, Subhi Y, Grauslund J, et al. Risk of post-injection endophthalmitis peaks within the first three injections of anti-vascular endothelial growth factor therapy: a nationwide registry-based study. Acta Ophthalmol. 2024. https:\/\/doi.org\/10.1111\/aos.16727.","journal-title":"Acta Ophthalmol"},{"key":"640_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.survophthal.2018.02.003","volume":"63","author":"B Clarke","year":"2018","unstructured":"Clarke B, Williamson TH, Gini G, Gupta B. Management of bacterial postoperative endophthalmitis and the role of vitrectomy. Surv Ophthalmol. 2018;63:677\u201393.","journal-title":"Surv Ophthalmol"},{"key":"640_CR11","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00417-012-1926-7","volume":"250","author":"AM Almanjoumi","year":"2012","unstructured":"Almanjoumi AM, Combey A, Romanet JP, Chiquet C. 23-gauge transconjunctival sutureless vitrectomy in treatment of post-operative endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 2012;250:1367\u201371.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"Suppl 12","key":"640_CR12","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/IAE.0000000000000399","volume":"34","author":"RL Avery","year":"2014","unstructured":"Avery RL, Bakri SJ, Blumenkranz MS, Brucker AJ, Cunningham ET Jr, D\u02bcAmico DJ, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34(Suppl 12):S1-18.","journal-title":"Retina"},{"key":"640_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0161-6420(80)35241-X","volume":"87","author":"RK Forster","year":"1980","unstructured":"Forster RK, Abbott RL, Gelender H. Management of infectious endophthalmitis. Ophthalmology. 1980;87:313\u20139.","journal-title":"Ophthalmology"},{"key":"640_CR14","doi-asserted-by":"publisher","first-page":"1355397","DOI":"10.3389\/fcimb.2024.1355397","volume":"14","author":"X Fu","year":"2024","unstructured":"Fu X, Du W, Huang L, Ren X, Chen D. Endophthalmitis: a bibliometric study and visualization analysis from 1993 to 2023. Front Cell Infect Microbiol. 2024;14:1355397.","journal-title":"Front Cell Infect Microbiol"},{"key":"640_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.sjopt.2012.02.011","volume":"26","author":"JR Safneck","year":"2012","unstructured":"Safneck JR. Endophthalmitis: a review of recent trends. Saudi J Ophthalmol. 2012;26:181\u20139.","journal-title":"Saudi J Ophthalmol"},{"key":"640_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.oret.2024.07.014","author":"M Tomaiuolo","year":"2024","unstructured":"Tomaiuolo M, Deaner J, VanderBeek BL, Acharya B, Syed ZA, Zhang Q, et al. Are treatment patterns for endophthalmitis after cataract surgery following the EVS trial recommendations? An IRIS\u00ae Registry analysis. Ophthalmol Retina. 2024. https:\/\/doi.org\/10.1016\/j.oret.2024.07.014.","journal-title":"Ophthalmol Retina."},{"key":"640_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2024.2749","author":"BL VanderBeek","year":"2024","unstructured":"VanderBeek BL, Chen Y, Tomaiuolo M, Deaner JD, Syed ZA, Acharya B, et al. Endophthalmitis rates and types of treatments after intraocular procedures. JAMA Ophthalmol. 2024. https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.2749.","journal-title":"JAMA Ophthalmol."},{"key":"640_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3310\/nihropenres.13469.1","volume":"3","author":"MMK Muqit","year":"2023","unstructured":"Muqit MMK, Pavesio C, Boston H, Sriharan K, Wang Y, Pizzo E, et al. A randomised controlled trial of early vitrectomy and intravitreal antibiotics for post-operative exogenous endophthalmitis (EVIAN study): study protocol for a feasibility trial. NIHR Open Res. 2023;3:47.","journal-title":"NIHR Open Res"},{"key":"640_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2024.01.012","author":"KA Stephenson","year":"2024","unstructured":"Stephenson KA, Merkur A, Kirker A, Albiani D, Pakzad-Vaezi K. Rates of endophthalmitis before and after transition from povidone-iodine to aqueous chlorhexidine asepsis for intravitreal injection. Can J Ophthalmol. 2024. https:\/\/doi.org\/10.1016\/j.jcjo.2024.01.012.","journal-title":"Can J Ophthalmol"},{"key":"640_CR20","doi-asserted-by":"publisher","first-page":"9212524","DOI":"10.1155\/2023\/9212524","volume":"2023","author":"B Davidov","year":"2023","unstructured":"Davidov B, Ohayon A, Trivizki O, Schwartz S, Shulman S. Postintravitreal injection endophthalmitis: incidence, characteristics, management, and outcome. J Ophthalmol. 2023;2023:9212524.","journal-title":"J Ophthalmol"},{"key":"640_CR21","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1097\/IAE.0000000000004143","volume":"44","author":"M Cioana","year":"2024","unstructured":"Cioana M, Naidu S, Far PM, Yeung SC, You Y, Yan P. Postintravitreal injection and postcataract extraction endophthalmitis visual outcomes by organism: a systematic review and meta-analysis. Retina. 2024;44:1608\u201318.","journal-title":"Retina"},{"key":"640_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3233\/THC-230607","volume":"32","author":"W-F Zhao","year":"2024","unstructured":"Zhao W-F, He W, Han Q-H, Qi S-X. Visual outcome of 25 Gauge vitrectomy for acute post operative infectious endophthalmitis. Technol Health Care. 2024;32:1099\u2013110.","journal-title":"Technol Health Care"},{"key":"640_CR23","doi-asserted-by":"publisher","first-page":"284","DOI":"10.4103\/tcmj.tcmj_14_24","volume":"36","author":"M Angelia","year":"2024","unstructured":"Angelia M, Amelia YS, Alberta IB, Tanto S, Pratama KG. Evaluating the efficacy of pars plana vitrectomy in the management of endophthalmitis after following the endophthalmitis vitrectomy study: a systematic review and meta-analysis. Tzu Chi Med J. 2024;36:284\u201390.","journal-title":"Tzu Chi Med J"}],"updated-by":[{"DOI":"10.1186\/s40942-025-00647-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000}}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-025-00640-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-025-00640-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:08:34Z","timestamp":1739855314000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-025-00640-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["640"],"URL":"https:\/\/doi.org\/10.1186\/s40942-025-00640-1","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"assertion":[{"value":"12 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The university's Ethics Committee approved the study (number 209\/2019) and informed consent was waived due to its retrospective nature.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}